Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and feasibility of neoadjuvant PD-1
blockade alone or neoadjuvant PD-1 blockade plus TPF induction chemotherapy in subjects with
resectable local advanced oral squamous cell carcinoma.